Corrigendum to "Determination of the Topology of Endoplasmic Reticulum Membrane Proteins Using Redox-sensitive Green-fluorescence Protein Fusions" [Biochim. Biophys. Acta 1853/7 (2015) 1672-1682] DOI 10.1016/j.bbamcr.2015.04.002;Determination of the topology of endoplasmic reticulum membrane proteins using redox-sensitive green-fluorescence protein fusions

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 7, 2015, Pages 1672-1682

  Tsachaki, Maria ^a   Birk, Julia ^a   Egert, Aurélie ^a   Odermatt, Alex ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

17 hydroxysteroid dehydrogenase; Endoplasmic reticulum; Green fluorescent protein; Live imaging; Redox sensor; Topology

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; 17BETA HYDROXYSTEROID DEHYDROGENASE 11; 17BETA HYDROXYSTEROID DEHYDROGENASE 12; 17BETA HYDROXYSTEROID DEHYDROGENASE 13; 17BETA HYDROXYSTEROID DEHYDROGENASE 6; 17BETA HYDROXYSTEROID DEHYDROGENASE 7; ENDOPLASMIC RETICULUM MEMBRANE PROTEIN; GREEN FLUORESCENT PROTEIN; MEMBRANE PROTEIN; REDOX SENSITIVE GREEN FLUORESCENT PROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; 3 (OR 17)-BETA-HYDROXYSTEROID DEHYDROGENASE; HYBRID PROTEIN; HYDROXYSTEROID DEHYDROGENASE;

ARTICLE; CATALYSIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOPLASMIC RETICULUM MEMBRANE; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; BIOLOGICAL MODEL; CELL FRACTIONATION; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHEMISTRY; COMPUTER SIMULATION; ENDOPLASMIC RETICULUM; HEK293 CELL LINE; HUMAN; INTRACELLULAR MEMBRANE; METABOLISM; OXIDATION REDUCTION REACTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 17-HYDROXYSTEROID DEHYDROGENASES; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; COMPUTER SIMULATION; ENDOPLASMIC RETICULUM; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; INTRACELLULAR MEMBRANES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; RECOMBINANT FUSION PROTEINS; SUBCELLULAR FRACTIONS;

EID: 84928350812     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.05.003     Document Type: Erratum

References (83)

1. Ai L.S., Lee Y.W., Chen S.S. Characterization of hepatitis C virus core protein multimerization and membrane envelopment: revelation of a cascade of core-membrane interactions. J. Virol. 2009, 83:9923-9939.
2. Frick C., Atanasov A.G., Arnold P., Ozols J., Odermatt A. Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase. J. Biol. Chem. 2004, 279:31131-31138.
3. Legeza B., Balazs Z., Nashev L.G., Odermatt A. The microsomal enzyme 17beta-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase. Endocrinology 2013, 154:205-213.
4. Ma B., Cui M.L., Sun H.J., Takada K., Mori H., Kamada H., Ezura H. Subcellular localization and membrane topology of the melon ethylene receptor CmERS1. Plant Physiol. 2006, 141:587-597.
5. Stambergova H., Skarydova L., Dunford J.E., Wsol V. Biochemical properties of human dehydrogenase/reductase (SDR family) member 7. Chem. Biol. Interact. 2014, 207:52-57.
6. Krawczyk E., Suprynowicz F.A., Sudarshan S.R., Schlegel R. Membrane orientation of the human papillomavirus type 16 E5 oncoprotein. J. Virol. 2010, 84:1696-1703.
7. De Strooper B., Beullens M., Contreras B., Levesque L., Craessaerts K., Cordell B., Moechars D., Bollen M., Fraser P., George-Hyslop P.S., Van Leuven F. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins. J. Biol. Chem. 1997, 272:3590-3598.
8. Davies J.P., Ioannou Y.A. Topological analysis of Niemann-Pick C1 protein reveals that the membrane orientation of the putative sterol-sensing domain is identical to those of 3-hydroxy-3-methylglutaryl-CoA reductase and sterol regulatory element binding protein cleavage-activating protein. J. Biol. Chem. 2000, 275:24367-24374.
9. Jung S.K., Morimoto R., Otsuka M., Omote H. Transmembrane topology of vesicular glutamate transporter 2. Biol. Pharm. Bull. 2006, 29:547-549.
10. Stone S.J., Levin M.C., Farese R.V. Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. J. Biol. Chem. 2006, 281:40273-40282.
11. Odermatt A., Becker S., Khanna V.K., Kurzydlowski K., Leisner E., Pette D., MacLennan D.H. Sarcolipin regulates the activity of SERCA1, the fast-twitch skeletal muscle sarcoplasmic reticulum Ca2+-ATPase. J. Biol. Chem. 1998, 273:12360-12369.
12. 2+ release channel of skeletal muscle sarcoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16725-16730.
13. Ren Y., Walker C., Loose-Mitchell D.S., Deng J., Ruan K.H., Kulmacz R.J. Topology of prostaglandin H synthase-1 in the endoplasmic reticulum membrane. Arch. Biochem. Biophys. 1995, 323:205-214.
14. Galvan D.L., Borrego-Diaz E., Perez P.J., Mignery G.A. Subunit oligomerization, and topology of the inositol 1,4, 5-trisphosphate receptor. J. Biol. Chem. 1999, 274:29483-29492.
15. Ruan K.H., Kulmacz R.J., Wilson A., Wu K.K. Highly sensitive fluorimetric enzyme immunoassay for prostaglandin H synthase solubilized from cultured cells. J. Immunol. Methods 1993, 162:23-30.
16. Lorenz H., Hailey D.W., Wunder C., Lippincott-Schwartz J. The fluorescence protease protection (FPP) assay to determine protein localization and membrane topology. Nat. Protoc. 2006, 1:276-279.
17. Lorenz H., Hailey D.W., Lippincott-Schwartz J. Fluorescence protease protection of GFP chimeras to reveal protein topology and subcellular localization. Nat. Methods 2006, 3:205-210.
18. Zamyatnin A.A., Solovyev A.G., Bozhkov P.V., Valkonen J.P., Morozov S.Y., Savenkov E.I. Assessment of the integral membrane protein topology in living cells. Plant J. 2006, 46:145-154.
19. Dooley C.T., Dore T.M., Hanson G.T., Jackson W.C., Remington S.J., Tsien R.Y. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J. Biol. Chem. 2004, 279:22284-22293.
20. Hanson G.T., Aggeler R., Oglesbee D., Cannon M., Capaldi R.A., Tsien R.Y., Remington S.J. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem. 2004, 279:13044-13053.
21. Meyer A.J., Dick T.P. Fluorescent protein-based redox probes. Antioxid. Redox Signal. 2010, 13:621-650.
22. Schwarzlander M., Fricker M.D., Muller C., Marty L., Brach T., Novak J., Sweetlove L.J., Hell R., Meyer A.J. Confocal imaging of glutathione redox potential in living plant cells. J. Microsc. 2008, 231:299-316.
23. Gutscher M., Pauleau A.L., Marty L., Brach T., Wabnitz G.H., Samstag Y., Meyer A.J., Dick T.P. Real-time imaging of the intracellular glutathione redox potential. Nat. Methods 2008, 5:553-559.
24. Birk J., Meyer M., Aller I., Hansen H.G., Odermatt A., Dick T.P., Meyer A.J., Appenzeller-Herzog C. Endoplasmic reticulum: reduced and oxidized glutathione revisited. J. Cell Sci. 2013, 126:1604-1617.
25. Gutscher M., Sobotta M.C., Wabnitz G.H., Ballikaya S., Meyer A.J., Samstag Y., Dick T.P. Proximity-based protein thiol oxidation by H2O2-scavenging peroxidases. J. Biol. Chem. 2009, 284:31532-31540.
26. Morgan B., Sobotta M.C., Dick T.P. Measuring E(GSH) and H2O2 with roGFP2-based redox probes. Free Radic. Biol. Med. 2011, 51:1943-1951.
27. Ozols J. Lumenal orientation and post-translational modifications of the liver microsomal 11 beta-hydroxysteroid dehydrogenase. J. Biol. Chem. 1995, 270:2305-2312.
28. Naray-Fejes-Toth A., Fejes-Toth G. Subcellular localization of the type 2 11beta-hydroxysteroid dehydrogenase. A green fluorescent protein study. J. Biol. Chem. 1996, 271:15436-15442.
29. Mziaut H., Korza G., Hand A.R., Gerard C., Ozols J. Targeting proteins to the lumen of endoplasmic reticulum using N-terminal domains of 11beta-hydroxysteroid dehydrogenase and the 50-kDa esterase. J. Biol. Chem. 1999, 274:14122-14129.
30. Odermatt A., Arnold P., Stauffer A., Frey B.M., Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J. Biol. Chem. 1999, 274:28762-28770.
31. Mindnich R., Moller G., Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol. Cell. Endocrinol. 2004, 218:7-20.
32. Marchais-Oberwinkler S., Henn C., Moller G., Klein T., Negri M., Oster A., Spadaro A., Werth R., Wetzel M., Xu K., Frotscher M., Hartmann R.W., Adamski J. 17beta-Hydroxysteroid dehydrogenases (17beta-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development. J. Steroid Biochem. Mol. Biol. 2011, 125:66-82.
33. Pasqualini J.R. Breast cancer and steroid metabolizing enzymes: the role of progestogens. Maturitas 2009, 65(Suppl. 1):S17-S21.
34. Adeniji A.O., Chen M., Penning T.M. AKR1C3 as a target in castrate resistant prostate cancer. J. Steroid Biochem. Mol. Biol. 2013, 137:136-149.
35. Salhab M., Reed M.J., Al Sarakbi W., Jiang W.G., Mokbel K. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer. Breast Cancer Res. Treat. 2006, 99:155-162.
36. Rizner T.L. Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer. Mol. Cell. Endocrinol. 2013, 381:124-139.
37. Byrns M.C., Jin Y., Penning T.M. Inhibitors of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights. J. Steroid Biochem. Mol. Biol. 2011, 125:95-104.
38. Poirier D. 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review. Expert Opin. Ther. Pat. 2010, 20:1123-1145.
39. Lin S.X., Poirier D., Adamski J. A challenge for medicinal chemistry by the 17beta-hydroxysteroid dehydrogenase superfamily: an integrated biological function and inhibition study. Curr. Top. Med. Chem. 2013, 13:1164-1171.
40. Poirier D. Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases. Anti Cancer Agents Med. Chem. 2009, 9:642-660.
41. Moon Y.A., Horton J.D. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J. Biol. Chem. 2003, 278:7335-7343.
42. Marijanovic Z., Laubner D., Moller G., Gege C., Husen B., Adamski J., Breitling R. Closing the gap: identification of human 3-ketosteroid reductase, the last unknown enzyme of mammalian cholesterol biosynthesis. Mol. Endocrinol. 2003, 17:1715-1725.
43. van Grunsven E.G., van Berkel E., Ijlst L., Vreken P., de Klerk J.B., Adamski J., Lemonde H., Clayton P.T., Cuebas D.A., Wanders R.J. Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2128-2133.
44. Kingston R.E., Chen C.A., Okayama H. Calcium phosphate transfection. Curr. Protoc. Immunol. 2001, Chapter 10. (Unit 10 13).
45. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157:105-132.
46. Bernsel A., Viklund H., Hennerdal A., Elofsson A. TOPCONS: consensus prediction of membrane protein topology. Nucleic Acids Res. 2009, 37:W465-W468.
47. Markus M., Husen B., Leenders F., Jungblut P.W., Hall P.F., Adamski J. The organelles containing porcine 17 beta-estradiol dehydrogenase are peroxisomes. Eur. J. Cell Biol. 1995, 68:263-267.
48. He X.Y., Merz G., Yang Y.Z., Mehta P., Schulz H., Yang S.Y. Characterization and localization of human type10 17beta-hydroxysteroid dehydrogenase. Eur. J. Biochem. 2001, 268:4899-4907.
49. Chen Z., Kastaniotis A.J., Miinalainen I.J., Rajaram V., Wierenga R.K., Hiltunen J.K. 17beta-hydroxysteroid dehydrogenase type 8 and carbonyl reductase type 4 assemble as a ketoacyl reductase of human mitochondrial FAS. FASEB J. 2009, 23:3682-3691.
50. Lukacik P., Keller B., Bunkoczi G., Kavanagh K.L., Lee W.H., Adamski J., Oppermann U. Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity. Biochem. J. 2007, 402:419-427.
51. Horiguchi Y., Araki M., Motojima K. Identification and characterization of the ER/lipid droplet-targeting sequence in 17beta-hydroxysteroid dehydrogenase type 11. Arch. Biochem. Biophys. 2008, 479:121-130.
52. Horiguchi Y., Araki M., Motojima K. 17beta-Hydroxysteroid dehydrogenase type 13 is a liver-specific lipid droplet-associated protein. Biochem. Biophys. Res. Commun. 2008, 370:235-238.
53. Hessa T., Meindl-Beinker N.M., Bernsel A., Kim H., Sato Y., Lerch-Bader M., Nilsson I., White S.H., von Heijne G. Molecular code for transmembrane-helix recognition by the Sec61 translocon. Nature 2007, 450:1026-1030.
54. Granseth E., Viklund H., Elofsson A. ZPRED: predicting the distance to the membrane center for residues in alpha-helical membrane proteins. Bioinformatics 2006, 22:e191-e196.
55. Bernsel A., Viklund H., Falk J., Lindahl E., von Heijne G., Elofsson A. Prediction of membrane-protein topology from first principles. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:7177-7181.
56. Lee H., Min J., von Heijne G., Kim H. Glycosylatable GFP as a compartment-specific membrane topology reporter. Biochem. Biophys. Res. Commun. 2012, 427:780-784.
57. Lee H., Lara P., Ostuni A., Presto J., Johansson J., Nilsson I., Kim H. Live-cell topology assessment of URG7, MRP6(1)(0)(2) and SP-C using glycosylatable green fluorescent protein in mammalian cells. Biochem. Biophys. Res. Commun. 2014, 450:1587-1592.
58. Avezov E., Cross B.C., Kaminski Schierle G.S., Winters M., Harding H.P., Melo E.P., Kaminski C.F., Ron D. Lifetime imaging of a fluorescent protein sensor reveals surprising stability of ER thiol redox. J. Cell Biol. 2013, 201:337-349.
59. van Lith M., Tiwari S., Pediani J., Milligan G., Bulleid N.J. Real-time monitoring of redox changes in the mammalian endoplasmic reticulum. J. Cell Sci. 2011, 124:2349-2356.
60. Odermatt A., Kratschmar D.V. Tissue-specific modulation of mineralocorticoid receptor function by 11beta-hydroxysteroid dehydrogenases: an overview. Mol. Cell. Endocrinol. 2012, 350:168-186.
61. Straume A.H., Knappskog S., Lonning P.E. Effects of SNP variants in the 17beta-HSD2 and 17beta-HSD7 genes and 17beta-HSD7 copy number on gene transcript and estradiol levels in breast cancer tissue. J. Steroid Biochem. Mol. Biol. 2014, 143C:192-198.
62. Han B., Li S., Song D., Poisson-Pare D., Liu G., Luu-The V., Ouellet J., Labrie F., Pelletier G. Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters. J. Steroid Biochem. Mol. Biol. 2008, 112:194-200.
63. Gunnarsson C., Hellqvist E., Stal O. 17beta-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer. Br. J. Cancer 2005, 92:547-552.
64. Suzuki T., Moriya T., Ariga N., Kaneko C., Kanazawa M., Sasano H. 17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Br. J. Cancer 2000, 82:518-523.
65. Oduwole O.O., Makinen M.J., Isomaa V.V., Pulkka A., Jernvall P., Karttunen T.J., Vihko P.T. 17Beta-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer. J. Steroid Biochem. Mol. Biol. 2003, 87:133-140.
66. English M.A., Hughes S.V., Kane K.F., Langman M.J., Stewart P.M., Hewison M. Oestrogen inactivation in the colon: analysis of the expression and regulation of 17beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer. Br. J. Cancer 2000, 83:550-558.
67. Wu L., Einstein M., Geissler W.M., Chan H.K., Elliston K.O., Andersson S. Expression cloning and characterization of human 17 beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20 alpha-hydroxysteroid dehydrogenase activity. J. Biol. Chem. 1993, 268:12964-12969.
68. Puranen T.J., Kurkela R.M., Lakkakorpi J.T., Poutanen M.H., Itaranta P.V., Melis J.P., Ghosh D., Vihko R.K., Vihko P.T. Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum. Endocrinology 1999, 140:3334-3341.
69. Wilfling F., Haas J.T., Walther T.C., Farese R.V. Lipid droplet biogenesis. Curr. Opin. Cell Biol. 2014, 29:39-45.
70. Pol A., Gross S.P., Parton R.G. Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites. J. Cell Biol. 2014, 204:635-646.
71. Fukami M., Homma K., Hasegawa T., Ogata T. Backdoor pathway for dihydrotestosterone biosynthesis: implications for normal and abnormal human sex development. Dev. Dyn. 2013, 242:320-329.
72. Biason-Lauber A., Miller W.L., Pandey A.V., Fluck C.E. Of marsupials and men: "Backdoor" dihydrotestosterone synthesis in male sexual differentiation. Mol. Cell. Endocrinol. 2013, 371:124-132.
73. Muthusamy S., Andersson S., Kim H.J., Butler R., Waage L., Bergerheim U., Gustafsson J.A. Estrogen receptor beta and 17beta-hydroxysteroid dehydrogenase type 6, a growth regulatory pathway that is lost in prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20090-20094.
74. Song D., Liu G., Luu-The V., Zhao D., Wang L., Zhang H., Xueling G., Li S., Desy L., Labrie F., Pelletier G. Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study. J. Steroid Biochem. Mol. Biol. 2006, 101:136-144.
75. Nokelainen P., Peltoketo H., Vihko R., Vihko P. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol. Endocrinol. 1998, 12:1048-1059.
76. Torn S., Nokelainen P., Kurkela R., Pulkka A., Menjivar M., Ghosh S., Coca-Prados M., Peltoketo H., Isomaa V., Vihko P. Production, purification, and functional analysis of recombinant human and mouse 17beta-hydroxysteroid dehydrogenase type 7. Biochem. Biophys. Res. Commun. 2003, 305:37-45.
77. Jokela H., Rantakari P., Lamminen T., Strauss L., Ola R., Mutka A.L., Gylling H., Miettinen T., Pakarinen P., Sainio K., Poutanen M. Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos. Endocrinology 2010, 151:1884-1892.
78. Luu-The V., Tremblay P., Labrie F. Characterization of type 12 17beta-hydroxysteroid dehydrogenase, an isoform of type 3 17beta-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 2006, 20:437-443.
79. Nagasaki S., Suzuki T., Miki Y., Akahira J., Kitada K., Ishida T., Handa H., Ohuchi N., Sasano H. 17Beta-hydroxysteroid dehydrogenase type 12 in human breast carcinoma: a prognostic factor via potential regulation of fatty acid synthesis. Cancer Res. 2009, 69:1392-1399.
80. Szajnik M., Szczepanski M.J., Elishaev E., Visus C., Lenzner D., Zabel M., Glura M., DeLeo A.B., Whiteside T.L. 17beta Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma. Gynecol. Oncol. 2012, 127:587-594.
81. Ohno Y., Suto S., Yamanaka M., Mizutani Y., Mitsutake S., Igarashi Y., Sassa T., Kihara A. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18439-18444.
82. Visus C., Ito D., Dhir R., Szczepanski M.J., Chang Y.J., Latimer J.J., Grant S.G., DeLeo A.B. Identification of Hydroxysteroid (17beta) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas. Cancer Immunol. Immunother. 2011, 60:919-929.
83. Joyce C.W., Shelness G.S., Davis M.A., Lee R.G., Skinner K., Anderson R.A., Rudel L.L. ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol. Biol. Cell 2000, 11:3675-3687.